文档库 最新最全的文档下载
当前位置:文档库 › 复发转移乳腺癌化学治疗基本原则2011

复发转移乳腺癌化学治疗基本原则2011

万方数据

万方数据

万方数据

复发转移乳腺癌化学治疗基本原则

作者:中国抗癌协会乳腺癌专业委员会, Breast Cancer Society Chinese Anti-Cancer

Association

作者单位:解放军军事医学科学院附属医院乳腺肿瘤科,北京,100071

刊名:

中华医学杂志

英文刊名:NATIONAL MEDICAL JOURNAL OF CHINA

年,卷(期):2011,91(2)

被引用次数:0次

参考文献(12条)

1.DeSantis C.Jemal A.Ward E Temporal trends in breast cancer mortality by state and race 2008

2.江泽飞.于世英.孙燕乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2008版) 2009

3.National Comprehensive Cancer Network2009 NCCN clinical practice guidelines for breast

cancer,Version 1 2009

4.O'Shaughnessy https://www.wendangku.net/doc/a85113602.html,es D.Vukelja S Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer:Phase Ⅲ trial results 2002

5.Cardoso F.Bedard PL.Winer EP International guidelines for management of metastatic breast

cancer:combination vs sequential single-agent chemotherapy 2009

6.Stockler M.Sourjina T.Grimison P A randomized trial of capecitabine (C) given intermittently (IC) versus continuously (CC) versus classical CMF as first line chemotherapy for women with advanced breast cancer (ABC) unsuited to more intensive treatment 2007(18S)

7.Slamon DJ.Leyland-Jones B.Shak S Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 2001

8.Marty M.Cognetti F.Maraninchi D Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:the M77001 study group 2005

9.Jackisch C HER-2-Positive metastatic breast cancer:Optimizing trastuzumab-based therapy 2006

10.Wardley AM.Pivot X.Morales-Vasquez F Randomized phase Ⅱ trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer 2007

11.Nielsen DL.Andersson M.Kamby C HER2-targeted therapy in breast cancer.Monoclonal antibodies and tyrosine kinase inhibitors 2009

12.Sánchez-Mu(n)oz A.Pérez-Ruiz E.Ribelles N Maintenance treatment in metastatic breast cancer 2008

本文链接:https://www.wendangku.net/doc/a85113602.html,/Periodical_zhyx201102001.aspx

授权使用:北京科技大学(bjkjdx),授权号:312331f9-12ae-4e5f-a354-9ebb00ca3b00

下载时间:2011年4月4日

相关文档